Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 2
2017 2
2019 1
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Docking Paradigm in Drug Design.
Sulimov VB, Kutov DC, Taschilova AS, Ilin IS, Tyrtyshnikov EE, Sulimov AV. Sulimov VB, et al. Among authors: sulimov av. Curr Top Med Chem. 2021;21(6):507-546. doi: 10.2174/1568026620666201207095626. Curr Top Med Chem. 2021. PMID: 33292135 Review.
Advances in Docking.
Sulimov VB, Kutov DC, Sulimov AV. Sulimov VB, et al. Among authors: sulimov av. Curr Med Chem. 2019;26(42):7555-7580. doi: 10.2174/0929867325666180904115000. Curr Med Chem. 2019. PMID: 30182836 Review.
New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation.
Novichikhina NP, Shestakov AS, Medvedeva SM, Lagutina AM, Krysin MY, Podoplelova NA, Panteleev MA, Ilin IS, Sulimov AV, Tashchilova AS, Sulimov VB, Geronikaki A, Shikhaliev KS. Novichikhina NP, et al. Among authors: sulimov av. Molecules. 2023 May 1;28(9):3851. doi: 10.3390/molecules28093851. Molecules. 2023. PMID: 37175261 Free PMC article.
Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa.
Skoptsova AA, Geronikaki A, Novichikhina NP, Sulimov AV, Ilin IS, Sulimov VB, Bykov GA, Podoplelova NA, Pyankov OV, Shikhaliev KS. Skoptsova AA, et al. Among authors: sulimov av. Molecules. 2024 Jan 11;29(2):373. doi: 10.3390/molecules29020373. Molecules. 2024. PMID: 38257286 Free PMC article.
Application of Molecular Modeling to Development of New Factor Xa Inhibitors.
Sulimov VB, Gribkova IV, Kochugaeva MP, Katkova EV, Sulimov AV, Kutov DC, Shikhaliev KS, Medvedeva SM, Krysin MY, Sinauridze EI, Ataullakhanov FI. Sulimov VB, et al. Among authors: sulimov av. Biomed Res Int. 2015;2015:120802. doi: 10.1155/2015/120802. Epub 2015 Sep 21. Biomed Res Int. 2015. PMID: 26484350 Free PMC article.
Application of the docking program SOL for CSAR benchmark.
Sulimov AV, Kutov DC, Oferkin IV, Katkova EV, Sulimov VB. Sulimov AV, et al. J Chem Inf Model. 2013 Aug 26;53(8):1946-56. doi: 10.1021/ci400094h. Epub 2013 Jul 24. J Chem Inf Model. 2013. PMID: 23829357